PROACT is a Prospective Master Protocol for a Cohort Study Focused on Evaluating the Implementation of Integrated Proactive Supportive Care Pathways at Gustave Roussy
NCT06479057 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 700
Last updated 2026-01-16
Summary
PROACT is a prospective master protocol for a cohort study focused on evaluating the implementation of integrated proactive pathways of supportive care.
This is an observational cohort study in the context of a quality-of-care initiative.
It will be evaluated by its impact on patient's distress measured by the NCCN's Distress thermometer at 12 weeks after entering the pathway.
Conditions
- Any Cancer
Interventions
- OTHER
-
Supportive Care Pathway
All pathways include a medical consultation with comprehensive needs assesment and evidence-based coordinated supportive care referrals at institutional and community-based level.
Sponsors & Collaborators
-
Gustave Roussy, Cancer Campus, Grand Paris
lead OTHER
Principal Investigators
-
Ines VAZ LUIS · Gustave Roussy, Cancer Campus, Grand Paris
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2024-01-11
- Primary Completion
- 2027-01-31
- Completion
- 2027-07-31
Countries
- France
Study Locations
More Related Trials
-
Neoadjuvant Lu-177-PSMA-617 in Patients With High Risk Localized Prostate Cancer Undergoing Radical Prostatectomy
NCT06798558 ·Status: RECRUITING ·Phase: PHASE2
-
PROSTACOX : Metastatic Prostate Chemotherapy
NCT00213694 ·Status: COMPLETED
-
Combination Chemotherapy in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy
NCT00006114 ·Status: UNKNOWN ·Phase: PHASE2
-
Treatment of Metastatic Castrate Resistant Prostate Cancer Patients According to Circulating Tumor Cells Kinetic
NCT03101046 ·Status: COMPLETED ·Phase: PHASE2
-
Search for Predictive Factors of Resistance to Treatment for Metastatic Castration-resistant Prostate Cancer by Studying the Expression of microRNAs
NCT04662996 ·Status: COMPLETED ·Phase: NA
-
Intraprostatic PRX302 Injection to Treat Localised Prostate Cancer
NCT03081481 ·Status: COMPLETED ·Phase: PHASE2
-
PRostate Olaparib Real World Evidence Study
NCT06031805 ·Status: RECRUITING
-
Study of Peri-Operative Docetaxel Plus Laparoscopic Radical Prostatectomy in Prostate Cancer Patients
NCT00127088 ·Status: SUSPENDED ·Phase: PHASE2
-
Implementation of Precision Medicine in High-risk Prostate Cancer
NCT06687421 ·Status: RECRUITING
-
PROCARE - PROstate Cancer Real World Evidence Registry
NCT06835218 ·Status: RECRUITING
-
To Live Better After Prostate Cancer Treatment:
NCT05100121 ·Status: RECRUITING ·Phase: NA
-
A Survivorship Care Plan and Embedded Navigation Tool
NCT03424837 ·Status: COMPLETED ·Phase: NA
-
A Phase 1/2 Clinical Trial to Evaluate the Safety, Tolerability, Dosimetry, and Anti-tumor Activity of Ga-68-NGUL / Lu-177-DGUL in Patients With Metastatic Castration-resistant Prostate Cancer (mCRPC) Refractory to Standard Therapy
NCT05547061 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1/PHASE2
-
PROStep: A Feasibility Trial Using PROs and Step Data to Monitor Patients With Lung and GI Cancers
NCT04616768 ·Status: COMPLETED ·Phase: PHASE3
-
A Study of Pertuzumab in Participants With Prostate Cancer
NCT02480010 ·Status: TERMINATED ·Phase: PHASE2
-
Trastuzumab in Treating Patients With Prostate Cancer
NCT00003740 ·Status: COMPLETED ·Phase: PHASE2
-
177 LuPSMA-617 vs Docetaxel in Metastatic Castration Resistant and PSMA-Positive Prostate Cancer
NCT04663997 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
A Study of 2141-V11 in Combination With Standard Treatments in People With Prostate Cancer
NCT06347705 ·Status: RECRUITING ·Phase: PHASE2
-
Influence of EMT on CTCs and Disease Progression in Prostate Cancer
NCT04021394 ·Status: COMPLETED
-
Hormone Suppression and Radiation Therapy for 6 Months With/Without Docetaxel for High Risk Prostate Cancer
NCT00116142 ·Status: COMPLETED ·Phase: PHASE3
-
Trial of Neoadjuvant Enoblituzumab vs SOC in Men With High-Risk Localized Prostate Cancer
NCT06014255 ·Status: RECRUITING ·Phase: PHASE2
-
A Study of Shorter Course Hormone Therapy and Radiation for High-risk Prostate Cancer
NCT05100472 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Relapse in Previously Irradiated Prostate Bed : Stereotactic Ablative Reirradiation Potentiated by Metformin
NCT04536805 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
Phase II High Dose Brachytherapy and Low Dose Rate Brachytherapy as Monotherapy in Localized Prostate Cancer
NCT02960087 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
A Randomized, Double-blind, Phase 3 Efficacy Trial of PROSTVAC-V/F +/- GM-CSF in Men With Asymptomatic or Minimally Symptomatic Metastatic Castrate-Resistant Prostate Cancer
NCT01322490 ·Status: COMPLETED ·Phase: PHASE3